Vivet Therapeutics is a startup based in Spain, 1 tracked investor.
Based in Spain, Vivet Therapeutics is a startup founded in 2018. Brouky records 1 investor associated with the company.
Vivet Therapeutics develops liver-directed gene therapies for rare genetic diseases, focusing on AAV-based treatments and technology to reduce neutralizing antibodies that limit gene therapy efficacy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.